The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo
about
Outbreaks of Ebola virus disease in Africa: the beginnings of a tragic sagaModeling of the Ebola virus delta peptide reveals a potential lytic sequence motifUpdates in diagnosis and management of Ebola hemorrhagic fever.Risks Posed by Reston, the Forgotten Ebolavirus.Anti-Ebola therapies based on monoclonal antibodies: current state and challenges ahead.Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNAHost genetic diversity enables Ebola hemorrhagic fever pathogenesis and resistance.Shed GP of Ebola virus triggers immune activation and increased vascular permeabilityAn upstream open reading frame modulates ebola virus polymerase translation and virus replication.Assessing the contribution of interferon antagonism to the virulence of West African Ebola virusesThe Glycoproteins of All Filovirus Species Use the Same Host Factors for Entry into Bat and Human Cells but Entry Efficiency Is Species Dependent.Delayed Disease Progression in Cynomolgus Macaques Infected with Ebola Virus Makona Strain.Changes associated with Ebola virus adaptation to novel species.Inclusion bodies are a site of ebolavirus replicationConserved differences in protein sequence determine the human pathogenicity of Ebolaviruses.Chimeric Filoviruses for Identification and Characterization of Monoclonal AntibodiesDevelopment and application of reporter-expressing mononegaviruses: current challenges and perspectives.Antibody-dependent-cellular-cytotoxicity-inducing antibodies significantly affect the post-exposure treatment of Ebola virus infectionHost cell factors in filovirus entry: novel players, new insightsCharacterization of host immune responses in Ebola virus infections.Ebolaviruses Associated with Differential Pathogenicity Induce Distinct Host Responses in Human Macrophages.Ebola Virus Replication and Disease Without Immunopathology in Mice Expressing Transgenes to Support Human Myeloid and Lymphoid Cell Engraftment.Transport of Ebolavirus Nucleocapsids Is Dependent on Actin Polymerization: Live-Cell Imaging Analysis of Ebolavirus-Infected Cells.The roles of ebolavirus glycoproteins in viral pathogenesis.Ebola virus infection modeling and identifiability problems.Forty Years of Ebolavirus Molecular Biology: Understanding a Novel Disease Agent Through the Development and Application of New Technologies.Generation of Recombinant Ebola Viruses Using Reverse Genetics.Reverse Genetics Systems for Filoviruses.Filovirus Strategies to Escape Antiviral Responses.Inhibition of Ebola virus glycoprotein-mediated cytotoxicity by targeting its transmembrane domain and cholesterol.Genetic Changes at the Glycoprotein Editing Site Associated With Serial Passage of Sudan Virus.Virology. Mutation rate and genotype variation of Ebola virus from Mali case sequences.Global and domestic legal preparedness and response: 2014 Ebola outbreak.Reverse Genetics of Filoviruses.Filovirus RefSeq entries: evaluation and selection of filovirus type variants, type sequences, and names.Severity of Disease in Humanized Mice Infected with Ebola Virus or Reston Virus is Associated with Magnitude of Early Viral Replication in Liver.Ebolaviruses: New roles for old proteins.A Critical Domain of Ebolavirus Envelope Glycoprotein Determines Glycoform and Infectivity.A genome-wide siRNA screen identifies a druggable host pathway essential for the Ebola virus life cycleGeneration of therapeutic antisera for emerging viral infections
P2860
Q21245402-5AC4E459-125B-4C69-9FA9-72E7249B7982Q28651528-6F8D2D70-177E-427E-A367-C8F4CBFD1872Q30238537-E82B9616-9377-4589-B66A-4EABD92DBF4AQ30239113-CF30F12B-E015-4DCA-9F73-0A1CFB2AD204Q30252022-229AD98F-5BD2-416E-87A4-9CAD256BD72BQ33568288-FBAA3C96-BE11-47FA-86E3-C4434EC64530Q34445647-316E17B3-8151-472E-8AFF-24204EF9CEE9Q34550148-70290C3D-799D-4F80-A731-44A36D62E5CEQ34574867-4295C6CE-43EA-4D61-B183-9424E4D88AFEQ35922893-F045BF56-2C96-4279-8D79-49D3A20095AFQ35930819-3246F2F3-2777-4557-BDD6-4A5305CFC3B9Q36121563-45DEFA53-2921-4D9A-9011-33E4470F3DE4Q36281532-299E3AFE-348B-4C74-9FFA-6645CC056E67Q36363434-F015C590-40E7-46E4-8232-C22BDF7A6152Q36724747-AB3E0C1B-72C5-440F-B425-37AAEDF4A90BQ36736403-3500F182-D311-4C8C-9C74-18972DDB6FD1Q37690397-F67FA571-60DA-4A35-9857-482309C1C4E8Q37728345-FF3629EF-8EF2-45F7-8DD3-6FFBCCE94763Q38076136-EE96F17B-075E-40F8-9DA0-6E27C028F19FQ38205274-EEA6744E-5238-4C94-8E8A-9C1C30109835Q38711125-ADA9263C-84AE-4B29-BB19-2A951EDBA0DDQ38823792-23BC14E2-3368-4D3C-8592-F6C893F9C1EEQ38868059-5923D6D8-3726-4A8F-A1BE-CCDAF47BEAA5Q39010678-E228F097-8591-48E5-AAAC-B014EE3BFC4EQ39013896-30C27F4C-8A8F-4E1B-A185-D7BB257342FAQ39345592-8E9B123B-4835-4843-B673-268B09A2A386Q40054473-B8CA68CE-C636-4EB9-9C6D-603A68308C28Q40056806-54CF1359-82E3-41CD-83F4-63057AFDDFD9Q40132236-1FF1BE00-8DE2-4585-A71D-76ED11F77E82Q40148056-1C7E553E-2F86-4C7A-AE5E-836144ABB82AQ40158371-05339377-D61C-4434-B6EC-F193EF554D6AQ40163432-056B917D-7D52-4B85-8F17-1E0C1A5737DAQ40187587-A0214341-4424-4A11-9806-A91C9261FB27Q41936032-FC5CBA81-A2FF-489C-8ECB-C3BCA040EB80Q42934343-A5057B03-75E9-4F5F-BDF5-1F2F789B5E0FQ44106069-9AC8738C-9750-4E77-ADBF-6FC5293635E0Q54221972-D1DE3F19-DCCF-433F-83D4-9CEAAFAC835CQ55044697-3924953C-7005-4AE9-B9A1-0F82C97ABF7FQ56906441-BA79256A-3222-490E-9914-33223DE4F3D3Q57483199-C5181DEE-240C-44D4-9096-C6D28CF9B3F7
P2860
The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo
@ast
The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo
@en
The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo
@en-gb
The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo
@nl
type
label
The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo
@ast
The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo
@en
The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo
@en-gb
The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo
@nl
prefLabel
The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo
@ast
The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo
@en
The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo
@en-gb
The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo
@nl
P2093
P2860
P50
P3181
P1433
P1476
The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo
@en
P2093
Allison Groseth
Astrid Herwig
Don Gardner
P2860
P304
P3181
P356
10.1371/JOURNAL.PPAT.1002847
P407
P577
2012-01-01T00:00:00Z